Quinolines and pharmaceutical compositions thereof

Details Quinolines and pharmaceutical compositions thereof Quinolines and pharmaceutical compositions thereof

2004-12-10

2009-08-18

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S153000, C546S157000, C546S167000

Reexamination Certificate

active

07576215

ABSTRACT:
This invention provides compounds of formula Ithat are useful in the treatment or inhibition of LXR mediated diseases.

REFERENCES:
patent: 4375544 (1983-03-01), Meth-Cohn et al.
patent: 4407803 (1983-10-01), Haviv et al.
patent: 4761419 (1988-08-01), Picard et al.
patent: 5183825 (1993-02-01), Kees
patent: 5593992 (1997-01-01), Adams et al.
patent: 5753675 (1998-05-01), Wattanasin
patent: 5817674 (1998-10-01), Clemence et al.
patent: 5837719 (1998-11-01), de Laszlo et al.
patent: 6004979 (1999-12-01), Clemence et al.
patent: 6172084 (2001-01-01), Cuny et al.
patent: 6495562 (2002-12-01), Bruncko et al.
patent: 6538022 (2003-03-01), Pollesello et al.
patent: 3905908 (1990-09-01), None
patent: 3927369 (1991-02-01), None
patent: 3935139 (1991-04-01), None
patent: 3935491 (1991-05-01), None
patent: 4139751 (1993-06-01), None
patent: 4243279 (1994-06-01), None
patent: 19532714 (1997-03-01), None
patent: 19709125 (1998-09-01), None
patent: 157362 (1985-10-01), None
patent: 0 304 063 (1988-08-01), None
patent: 529450 (1990-03-01), None
patent: 372657 (1990-06-01), None
patent: 387610 (1990-09-01), None
patent: 399291 (1990-11-01), None
patent: 414076 (1991-02-01), None
patent: 414078 (1991-02-01), None
patent: 418071 (1991-03-01), None
patent: 466452 (1992-01-01), None
patent: 0498723 (1992-08-01), None
patent: 498723 (1992-08-01), None
patent: 499926 (1992-08-01), None
patent: 509359 (1992-10-01), None
patent: 535548 (1993-04-01), None
patent: 545170 (1993-06-01), None
patent: 545171 (1993-06-01), None
patent: 570112 (1993-11-01), None
patent: 582908 (1994-02-01), None
patent: 0628550 (1994-06-01), None
patent: 675111 (1995-10-01), None
patent: 720987 (1996-07-01), None
patent: 720988 (1996-07-01), None
patent: 808627 (1997-11-01), None
patent: 808628 (1997-11-01), None
patent: 812841 (1997-12-01), None
patent: 1106612 (2001-06-01), None
patent: 1270535 (2003-01-01), None
patent: 2827599 (2003-01-01), None
patent: 4-182469 (1992-06-01), None
patent: 05-043589 (1993-02-01), None
patent: 5-130897 (1993-05-01), None
patent: 95-128327 (1993-08-01), None
patent: 06092939 (1994-04-01), None
patent: 6-92939 (1994-05-01), None
patent: 07-010870 (1995-01-01), None
patent: 07089957 (1995-04-01), None
patent: 10067658 (1998-10-01), None
patent: 2002-371078 (2002-12-01), None
patent: WO 91/09017 (1991-06-01), None
patent: WO 93/07124 (1992-09-01), None
patent: WO 02/090375 (1992-11-01), None
patent: WO 92/19614 (1992-11-01), None
patent: WO 93/14081 (1993-07-01), None
patent: WO 95/07922 (1995-03-01), None
patent: WO 95/10505 (1995-04-01), None
patent: WO 96/01830 (1996-01-01), None
patent: WO 96/06840 (1996-03-01), None
patent: WO 97/34893 (1997-09-01), None
patent: WO 97/44036 (1997-11-01), None
patent: WO 98/14430 (1998-04-01), None
patent: WO 98/20007 (1998-05-01), None
patent: WO 98/34115 (1998-08-01), None
patent: WO 99/01130 (1999-01-01), None
patent: WO 99/31086 (1999-06-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/13681 (2000-03-01), None
patent: WO 00/13682 (2000-03-01), None
patent: WO 00/31063 (2000-06-01), None
patent: WO 00/42026 (2000-07-01), None
patent: WO 00/54759 (2000-09-01), None
patent: WO 01/41704 (2001-06-01), None
patent: WO 01/55140 (2001-08-01), None
patent: WO 01/56552 (2001-08-01), None
patent: WO 01/62234 (2001-08-01), None
patent: WO 01/64197 (2001-09-01), None
patent: WO 01/64199 (2001-09-01), None
patent: WO 01/64217 (2001-09-01), None
patent: WO 01/64218 (2001-09-01), None
patent: WO 01/64226 (2001-09-01), None
patent: WO 01/64246 (2001-09-01), None
patent: WO 01/64252 (2001-09-01), None
patent: WO 01/70227 (2001-09-01), None
patent: WO 01/70228 (2001-09-01), None
patent: WO 01/70698 (2001-09-01), None
patent: WO 01/82917 (2001-11-01), None
patent: WO 02/12191 (2002-02-01), None
patent: WO 02/26713 (2002-04-01), None
patent: WO 02/30407 (2002-04-01), None
patent: WO 02/30426 (2002-04-01), None
patent: WO 02/43733 (2002-06-01), None
patent: WO 02/085364 (2002-10-01), None
patent: WO 02/096397 (2002-12-01), None
patent: WO 03/013523 (2003-02-01), None
patent: WO 03/024441 (2003-03-01), None
patent: WO 03/031408 (2003-04-01), None
patent: WO 03/082198 (2003-10-01), None
Clemence, abstract only CA118:22153, abstract only of EP 498722, Aug. 1992.
Cao G. et al. “Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis,”J. Biol. Chem. (2003) 278(2)1131-1136.
Collins J.L. et al., “Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary,”J. Med. Chem. (2000) 45:1963-1966.
Joseph S.B. et al., “Reciprocal regulation of inflammation and lipid metabolism by liver X receptors,”Nat Med. (2003) 9(2):213-9.
Joseph S.B. et al., “LXRs: new therapeutic targets in atherosclerosis?,”Current Opinion in Pharmacology(2003) 3:192-197.
Green, T.W. et al., “Productive Groups in Organic Synthesis,” 3rdEdition, New York: John Wiley & Sons (1999).
Schultz, J.R. et al., “Role of LXRs in control of lipogenesis,”Genes&Development(2000) 14(22):2831-2838.
Smith, Michael B. and March, Joseph, March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 5thEdition, New York: John Wiley & Sons (2001).
Sun Y. et al. “Expression of liver X receptor target genes decreases cellular amyloid β peptide secretion*,”J. Biol. Chem. (2003) 278(30):27688-27694.
Ohnmacht, Jr. et al., “Antimalarials. 5. .α.-Dibutylaminomethyl- and .alpha.-(2-piperidyl)-3-quinolinemethanols,”Journal of Medicinal Chemistry(1971) 14(1):17-24.
Gallagher et al., “Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase,”Bioorganic&Medicinal Chemistry(1997) 5(1):49-64.
Akeson et al., “Suppression of interleukin-1β and LDL scavenger receptor expression in macrophages by a selective protein kinase C inhibitor,”Journal of Lipid Research(1991) 32(10):1699-1707.
Joseph et al., “Synthetic LXR ligand inhibits the development of atherosclerosis in mice,”PNAS(2002) 99(11):7604-7609.
Partial International Search Report dated Jun. 3, 2005 for International Application No. PCT/US2004/041399.
Spencer, T., et al., “Pharmacophore analysis of the nuclear oxysterol receptor LXR alpha,”J. of Med. Chem(2001) 44(6):886-97.
Janowski, B., et al., “Structural requirements of ligands for the oxysterol liver X receptors LXR alpha and LXR beta,”Proceedings of the National Academy of Sciences of the United States of America(1999) 96:266-71.
International Search report mailed Sep. 19, 2005 from International Application No. PCT/US2004/041399.

Affiliated with

Also associated with

Rating

Quinolines and pharmaceutical compositions thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinolines and pharmaceutical compositions thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolines and pharmaceutical compositions thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4133847